Novotech Publishes Report on the Global COVID-19 Clinical Trial Landscape, Highlighting Key Trends, Therapeutic Advancements, and Challenges in Drug Development December 19, 2024
From Crisis to Opportunity: Can Karnataka Reform Its Education System After CAG Exposes Rs 345 Crore Fee Overcharge During Covid-19? December 15, 2024
PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen November 14, 2024
Chronic Exposure to Air Pollution May Increase Risks for ICU Admission or Death Among COVID-19 Patients, Study Finds | Mount Sinai October 30, 2024
Depression, loneliness associated with increased hospitalization risk after COVID-19, NIH-funded study suggests October 29, 2024
New paper using Attana Technology: A broadly potent antibody targeting the different Covid-19 mutations October 9, 2024
